New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
16:10 EDTQGENQIAGEN gains FDA approval to market careHPV test in China
QIAGEN announced that China's State Food and Drug Administration has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagnostic to screen for high risk human papillomavirus, or HPV, designed for low-resource clinical settings, such as areas lacking electricity, water or modern laboratory infrastructure. QIAGEN expects to announce the product availability of careHPV in China in January 2013, followed by India later in 2013 and other emerging markets as approvals are received. QIAGEN will introduce the careHPV Test and key data of its performance at the International Papillomavirus, or IPV, conference, starting November 30 in Puerto Rico.
News For QGEN From The Last 14 Days
Check below for free stories on QGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 15, 2014
16:05 EDTQGENQIAGEN launches 14 new cancer gene panels
Subscribe for More Information
July 10, 2014
10:05 EDTQGENOn The Fly: Analyst Initiation Summary
Subscribe for More Information
July 9, 2014
16:41 EDTQGENQIAGEN initiated with a Market Perform at Wells Fargo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use